Characteristics of immune microenvironment and progress of immune checkpoint inhibitors to cholangiocarcinoma treatment / 中华肝胆外科杂志
Chinese Journal of Hepatobiliary Surgery
;
(12): 466-471, 2021.
Article
in Chinese
| WPRIM
| ID: wpr-910575
ABSTRACT
Cholangiocarcinoma is a highly malignant disease with low surgical resection rate. It’s resistant to chemoradiotherapy and the prognosis of cholangiocarcinoma is poor. Although immune checkpoint inhibitors (ICIs) have achieved great success in tumor therapy in recent years, patients with cholangiocarcinoma have a poor response to immunotherapy, because of the complexity and diversity of immune microenvironment. Therefore, understanding the composition and characteristics of the immune microenvironment of cholangiocarcinoma, regulating targets in immune microenvironment, and adopting ICIs combined therapy, is important for immunotherapy for cholangiocarcinoma.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prognostic study
Language:
Chinese
Journal:
Chinese Journal of Hepatobiliary Surgery
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS